BLNE
Beeline Holdings, Inc.
There isn't enough reported data to score BLNE yet.
CELH
Celsius Holdings, Inc.
CELH's fundamentals are strong and it looks cheap: trading at 35x earnings, less than half its usual 142x. Analysts expect strong earnings growth, though they disagree widely on how much.
BLNE Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Unavailable | |
| Unavailable |
BLNE's revenue is currently strong, but its profitability is weak. There isn't enough data to rate its cash flow and balance sheet.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
BLNE PE Valuation
BLNE has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 1.8x next year's earnings.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
BLNE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect BLNE to return to profit, with revenue growing.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
BLNE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.32 | — |
| Q3 2023 | -$185.60 | -$62.14 |
| Q2 2023 | -$201.60 | -$50.14 |
| Q1 2023 | -$206.00 | -$50.54 |
| Q4 2022 | -$214.00 | -$148.54 |
| Q3 2022 | -$123.46 | -$47.46 |
| Q2 2022 | -$151.46 | -$105.46 |
| Q1 2022 | -$155.46 | -$93.46 |
| Q4 2021 | -$65.46 | +$130.54 |
CELH has the stronger earnings trend. Trailing diluted EPS is down 128% for BLNE versus CELH up 718%.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
BLNE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3M | +29% |
| Q2 2026 | $2.6M | +53% |
| Q1 2026 | $2.7M | +47% |
| Q4 2025 | $2.4M | +31% |
| Q3 2025 | $2.3M | +208% |
| Q2 2025 | $1.7M | -42% |
| Q1 2025 | $1.8M | -24% |
| Q4 2024 | $1.8M | -10% |
BLNE's revenue is recovering but still below its 2022 peak: $3M last quarter, up 29% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -125% | -4.4 points |
| Q2 2026 | -171% | +58 points |
| Q1 2026 | -192% | +77 points |
| Q4 2025 | -342% | +86 points |
| Q3 2025 | -121% | -61 points |
| Q2 2025 | -229% | -189 points |
| Q1 2025 | -269% | -225 points |
| Q4 2024 | -428% | -352 points |
BLNE's operating margin was −125% last quarter, down 4.4 points from the same quarter a year ago.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over BLNE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over BLNE on profitability, with a higher operating margin.
BLNE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$106K | +$5.7M |
| Q1 2026 | -$3.6M | -$2.2M |
| Q4 2024 | -$1.6M | -$1.5M |
| Q4 2023 | -$134K | +$896K |
| Q3 2023 | -$1.2M | -$1.1M |
| Q2 2023 | -$256K | +$445K |
| Q1 2023 | -$456K | +$1.1M |
| Q4 2022 | -$1M | +$2.3M |
CELH has the stronger cash trend. Its trailing FCF is up 100% versus its history, compared with BLNE at down 165%.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
BLNE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +6.8% | +2.1M shares |
| 1 year | +242% | +23.7M shares |
| 3 years | +52672% | +33.5M shares |
| 5 years | +72200% | +33.5M shares |
BLNE has 34M diluted shares, up 242% from a year ago.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over BLNE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
BLNE Net Leverage
BLNE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
BLNE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.0 | Neutral |
| Stochastic | 5.9 | Oversold |
BLNE's weekly RSI is 31 (neutral) and its Stochastic is 6 (oversold).
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
BLNE PE vs Consumer Defensive Sector
BLNE has no meaningful PE right now: it lost money over the past year.
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
BLNE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.72 | 18% below |
| 20 week MA | $0.89 | 34% below |
| 50 week MA | $1.66 | 64% below |
| 100 week MA | $2.49 | 76% below |
| 200 week MA | $11.6 | 95% below |
BLNE is in a downtrend: it's below all five of its weekly moving averages, and 95% below its 200-week average.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has the edge over BLNE on trend strength, trading above more of its moving averages.
BLNE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $600.0 | $250.0 | -58% |
| 2021 | $250.0 | $370.0 | +48% |
| 2022 | $370.0 | $50.0 | -86% |
| 2023 | $50.0 | $12.9 | -74% |
| 2024 | $12.9 | $8.40 | -35% |
| 2025 | $8.40 | $1.96 | -77% |
| 2026 YTD | $1.96 | $0.59 | -70% |
BLNE has finished four years in a row lower, and it's down 70% so far in 2026.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH has the edge over BLNE on returns for 2026, with the stronger performance.